Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA
- PMID: 8854885
- DOI: 10.1007/BF02528774
Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA
Abstract
Topoisomerase I is believed to be sufficient for early replication of circular viral genomes such as those of SV40 and of yeast plasmids. Topoisomerase II is required for the decatenation of the daughter genomes and probably also for fork elongation during the later stages of SV40 replication. Using the neutral-neutral two-dimensional gel system, we have followed the progression of replication of both SV40 and the yeast 2 micron plasmid under various conditions of topoisomerase inhibition. During SV40 replication, inhibition of topoisomerase II by VP16, VM26 or hypertonic shock (but not by merbarone), and inhibition of topoisomerase I by camptothecin all led to the accumulation of aberrant DNA structures containing two almost completely replicated genomes. These aberrant structures resembled either recombination intermediates or late Cairns structures in which the site of replication termination had shifted and now mapped to a continuum of sites throughout the genome. Replication of the 2 micron plasmid in a topoisomerase II- but not a topoisomerase I-deficient yeast gave rise to very similar structures. The data suggest that inactivation of topoisomerase I or II either stimulates recombination or, by differentially affecting replication fork progression, leads to aberrant replication termination.
Similar articles
-
Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitro.Nucleic Acids Res. 1988 Nov 11;16(21):10119-29. doi: 10.1093/nar/16.21.10119. Nucleic Acids Res. 1988. PMID: 2848217 Free PMC article.
-
Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.J Virol. 1990 Feb;64(2):691-9. doi: 10.1128/JVI.64.2.691-699.1990. J Virol. 1990. PMID: 2153235 Free PMC article.
-
Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.J Virol. 1990 Jan;64(1):78-85. doi: 10.1128/JVI.64.1.78-85.1990. J Virol. 1990. PMID: 2152835 Free PMC article.
-
Yeast as a genetic model system for studying topoisomerase inhibitors.Adv Pharmacol. 1994;29B:201-26. doi: 10.1016/s1054-3589(08)61139-4. Adv Pharmacol. 1994. PMID: 8996609 Review. No abstract available.
-
SV40 DNA replication intermediates: analysis of drugs which target mammalian DNA replication.Bioessays. 1993 Feb;15(2):121-7. doi: 10.1002/bies.950150208. Bioessays. 1993. PMID: 8385943 Review.
Cited by
-
Bi-directional replication and random termination.Nucleic Acids Res. 2000 May 15;28(10):2099-107. doi: 10.1093/nar/28.10.2099. Nucleic Acids Res. 2000. PMID: 10773078 Free PMC article.
-
Rad52-independent accumulation of joint circular minichromosomes during S phase in Saccharomyces cerevisiae.Mol Cell Biol. 2003 Sep;23(18):6363-72. doi: 10.1128/MCB.23.18.6363-6372.2003. Mol Cell Biol. 2003. PMID: 12944465 Free PMC article.
-
Topoisomerase III acts upstream of Rad53p in the S-phase DNA damage checkpoint.Mol Cell Biol. 2001 Nov;21(21):7150-62. doi: 10.1128/MCB.21.21.7150-7162.2001. Mol Cell Biol. 2001. PMID: 11585898 Free PMC article.
-
Top2 and Sgs1-Top3 Act Redundantly to Ensure rDNA Replication Termination.PLoS Genet. 2015 Dec 2;11(12):e1005697. doi: 10.1371/journal.pgen.1005697. eCollection 2015 Dec. PLoS Genet. 2015. PMID: 26630413 Free PMC article.
-
Hemicatenanes form upon inhibition of DNA replication.Nucleic Acids Res. 2000 May 15;28(10):2187-93. doi: 10.1093/nar/28.10.2187. Nucleic Acids Res. 2000. PMID: 10773090 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources